Neuroendocrine response to the serotonin agonist m-chlorophenylpiperazine in women with menstrual status migrainosus

Neuroendocrinology

Volumn 78, Issue 1, 2003, Pages 52-60

  Nappi, Rossella E ^a,b   Sances, Grazia ^b,c   Brundu, Benedetta ^a   Ghiotto, Natascia ^b,c   Detaddei, Silvia ^a   Biancardi, Caterina ^b,c   Polatti, Franco ^a   Nappi, Giuseppe ^b,d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adrenal steroids; Clinical neuroendocrinology; m Chlorophenylpiperazine; Menstrual migraine; Prolactin; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; HYDROCORTISONE; PROLACTIN; RECEPTOR SUBTYPE; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR PHASE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LUTEAL PHASE; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MENSTRUAL STATUS MIGRAINOSUS; MENSTRUATION; MULTIVARIATE ANALYSIS OF VARIANCE; NEUROENDOCRINE SYSTEM; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; ANIMALS; FEMALE; HUMANS; HYDROCORTISONE; MENSTRUAL CYCLE; MIGRAINE DISORDERS; PIPERAZINES; PROLACTIN; SEROTONIN AGONISTS;

EID: 0042665850     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071706     Document Type: Article

References (40)

1. Raskin NH: Serotonin receptors and headache. N Engl J Med 1991;325:353-354.
2. Goadsby PJ, Lipton RB, Ferrari MD: Migraine - Current understanding and treatment. N Engl J Med 2002;346:257-270.
3. MacGregor EA: 'Menstrual' migraine: Towards a definition. Cephalalgia 1996;16:11-21.
4. Boyle CA: Management of menstrual migraine. Neurology 1999;53:S14-S18.
5. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:10-73.
6. Couch JR Jr, Diamond S: Status migrainosus: Causative and therapeutic aspects. Headache 1983;23:94-101.
7. Fioroni L, Martignoni E, Facchinetti F: Changes of neuroendocrine axes in patients with menstrual migraine. Cephalalgia 1995;15:297-300.
8. Basbaum AI, Fields HL: Endogenous pain control system: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;7:309-338.
9. Murphy DL, Aulakh C, Mazzola-Pomietto P, Briggs NC: Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: A preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behav Brain Res 1996;73:209-214.
10. Hoyer D, Clarke DE, Fozard JR, et al: International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157-203.
11. Kahn RS, Wetzler S: m-Chlorophenylpiperazine as a probe of serotoninergic function. Biol Psychiatry 1991;30:1139-1166.
12. Baumann MH, Mash DC, Staley JK: The serotonin agonist m-chlorophenylpiperazine (m-CPP) binds to serotonin transporter sites in human brain. Neuroreport 1995;6:2150-2152.
13. Mueller EA, Murphy DL, Sunderland T: Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab 1985;61:1179-1185.
14. Charney DS, Woodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR: Serotonin function in obsessive-compulsive disorder: a comparison of the effects of tryptophan and mchlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 1988;45:177-185.
15. Charney DS, Woods SW, Goodman WK, Heninger GR: Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 1987;92:14-24.
16. Brewerton TD, Mueller EA, Lesem MD, et al. Neuroendocrine responses to m-chlorophenylpiperazine and l-tryptophan in bulimia. Arch Gen Psychiatry 1992;49:852-861.
17. Anand A, Charney DS, Delgado PL, McDougle CJ, Heninger GR, Price LH: Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry 1994;151:1626-1630.
18. Su TP, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR: Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 1997;82:1220-1228.
19. Aulakh CS, Hill JL, Murphy DL: Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 1992;263:588-595.
20. Meltzer HY, Maes M: Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Psychiatry Res 1995;58:89-98.
21. Leone M, Attanasio A, Croci D, et al: The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study. Neurology 2000;55:136-139.
22. Leone M, Attanasio A, Croci D, et al: The m-chlorophenylpiperazine test in cluster headache: A study on central serotoninergic activity. Cephalalgia 1997;17:666-672.
23. 1D) agonists and other agents in acute migraine. Neurol Clin 1997;15:61-83.
24. Silberstein SD, Goadsby PJ, Lipton RB: Management of migraine: An algorithmic approach. Neurology 2000;55(suppl 2):S46-S52.
25. Petraglia F, Facchinetti F, Martignoni E, Nappi G, Volpe A, Genazzani AR: Serotoninergic agonists increase plasma levels of beta-endorphin and beta-lipotropin in humans. J Clin Endocrinol Metab 1984;59:1138-1142.
26. Facchinetti F, Nappi RE, Sances G, Fioroni L, Nappi G, Genazzani AR: The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. Clin Endocrinol (Oxf) 1994;40:211-214.
27. Nappi G, Facchinetti F, Rossi F (eds): Headache and menstrually related disorders: In search of a consensus. Cephalalgia 1997;17(suppl 20).
28. Silberstein SD, Lipton RB, Goadsby PJ: Headache in Clinical Practice. Oxford, Isis Medical Media, 1998, pp 61-90.
29. Massiou H, Bousser M-G: Influence of female hormones on migraine; in Olesen J, Tfelt-Hansen P, Welch KMA (eds): The Headaches, ed 2. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 261-267.
30. Nappi RE, Veneroni F, Chiapparini I, et al: Gonadal hormones and migraine: A tight bondage within the female brain. Semin Headache Manage 1999;4:11-15.
31. Petraglia F, Martignoni E, Sola D, Cicoli C, Facchinetti F, Nappi G, Genazzani AR: Evaluation of central opioid tonus in menstrual migraine. Cephalalgia 1983;98-100.
32. Nappi RE, Bonneau MJ, Rivest S: Influence of the estrous cycle on c-fos and CRH gene transcription in the brain of endotoxin-challenged female rats. Neuroendocrinology 1997;65:29-46.
33. Facchinetti F, Martignoni E, Fioroni L, Sances G, Genazzani AR: Opioid control of the hypothalamus-pituitary-adrenal axis cyclically fails in menstrual migraine. Cephalalgia 1990;10:51-56.
34. Fioroni L, Andrea GD, Alecci M, Cananzi A, Facchinetti F: Platelet serotonin pathway in menstrual migraine. Cephalalgia 1996;16:427-430.
35. Anthony M. Amine metabolism in migraine; in Blau JN (ed): Migraine. Baltimore, John Hopkins University Press, 1987, pp 303-329.
36. Leone M, Attanasio A, Croci D, et al: 5-HT1A receptor hypersensitivity in migraine is suggested by the m-chlorophenylpiperazine test. Neuroreport 1998;9:2605-2608.
37. Gordon ML, Lipton RB, Brown SL, et al: Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Cephalalgia 1993;13:400-405.
38. Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP: Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axus in the rat. Endocrinology 1990;126:1888-1894.
39. Peroutka SJ: Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatry 1985;20:971-979.
40. Facchinetti F, Neri I, Martignoni E, Fioroni L, Nappi G, Genazzani AR: The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993;13:422-425.